bpc-157 clinical trial multiple sclerosis The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity BPC-157 as an Investigational Peptide
Description
Most patients find their optimal maintenance dose somewhere between 5 mg and 15 mg weekly
It stimulates lipolysis and inhibits lipogenesis, targeting fat metabolism directly
equi 85FP + strain
My journey with this peptide has been nothing short of amazing
Use doses that restore testosterone to age-related normal values
